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Transcription initiates at both coding and noncoding genomic elements, including mRNA and long noncoding RNA
(lncRNA) core promoters and enhancer RNAs (eRNAs). However, each class has a different expression profile with
lncRNAs and eRNAs being the most tissue specific. How these complex differences in expression profiles and tissue speci-
ficities are encoded in a single DNA sequence remains unresolved. Here, we address this question using computational ap-
proaches and massively parallel reporter assays (MPRA) surveying hundreds of promoters and enhancers. We find that
both divergent lncRNA and mRNA core promoters have higher capacities to drive transcription than nondivergent
lncRNA and mRNA core promoters, respectively. Conversely, intergenic lncRNAs (lincRNAs) and eRNAs have lower ca-
pacities to drive transcription and are more tissue specific than divergent genes. This higher tissue specificity is strongly as-
sociated with having less complex transcription factor (TF) motif profiles at the core promoter. We experimentally validated
these findings by testing both engineered single-nucleotide deletions and human single-nucleotide polymorphisms (SNPs) in
MPRA. In both cases, we observe that single nucleotides associated with many motifs are important drivers of promoter ac-
tivity. Thus, we suggest that high TF motif density serves as a robust mechanism to increase promoter activity at the expense
of tissue specificity. Moreover, we find that 22% of common SNPs in core promoter regions have significant regulatory ef-
fects. Collectively, our findings show that high TF motif density provides redundancy and increases promoter activity at the
expense of tissue specificity, suggesting that specificity of expression may be regulated by simplicity of motif usage.
[Supplemental material is available for this article.]
Transcription factors (TFs) regulate gene expression by binding to
DNA regulatory elements at both coding and noncoding genomic
elements, including mRNA and long noncoding RNA (lncRNA)
promoters and enhancers. Classically, promoters and enhancers
have been defined as distinct categories of regulatory elements.
However, recent findings suggest that promoters and enhancers
share a common regulatory code, as transcription is initiated at
both (Core et al. 2008; Engreitz et al. 2016). Indeed, at bothpromot-
ers and enhancers, RNA polymerase II (Pol II) binds to a 50- to
100-bp stretch of DNA termed the “core promoter” and transcribes
inboth the sense andantisensedirections—aphenomenonknown
as bidirectional transcription (Andersson2015). Such transcription
at promoters typically produces long, stable polyadenylated
transcripts in the sense direction and short, unstable, nonpolyade-
nylated transcripts in the antisense direction (Andersson 2015). At
enhancers, highly unstable RNAs, named enhancer RNAs (eRNAs),
are produced in a bidirectionalmanner (The FANTOMConsortium
and the RIKEN PMI and CLST [DGT] 2014).
Although almost all promoters exhibit bidirectional tran-
scription, in some cases, this bidirectional transcription results in
two stable transcripts that are arranged in a “head-to-head” orien-
tation (one on the sense strand and one on the antisense strand).
These so-called “divergent” transcripts are abundant in the human
genome, are evolutionarily conserved, and often comprised of two
highly expressed individual core promoter sequences (Trinklein
et al. 2004). It remains unclear, however, whether their high ex-
pression levels are a byproduct of having two promoters in close
proximity or whether it is an inherent property of their DNA se-
quence. Additionally, these divergent transcript pairs can also in-
clude lncRNAs, but whether divergent lncRNA promoters have
distinct regulatory properties compared to divergent mRNA pro-
moters is also unknown.
Like mRNAs, lncRNAs are transcribed by Pol II, canonically
spliced, and polyadenylated. However, lncRNAs also show similar-
ities to enhancers: They have similar chromatin environments
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(Marques et al. 2013), and they often act as enhancers themselves
by activating the transcription of nearby genes (Rinn and Chang
2012; Ørom and Shiekhattar 2013). As a class, lncRNAs are known
to be more lowly expressed and more tissue specific than protein-
coding genes (Cabili et al. 2011; Derrien et al. 2012; Molyneaux
et al. 2015). Although lncRNAs are less conserved than protein-
coding genes, their promoters—and the TF binding sites within
their promoters—are well-conserved (Ponjavic et al. 2007; Melé
et al. 2017), suggesting that a conserved regulatory logic controls
lncRNA transcription. However, the rules that govern lncRNA
transcription and that determine their higher tissue specificity re-
main unclear. For example, it is unknown whether lncRNAs are
more tissue specific than mRNAs due to differences in their TF
binding profiles.
In this work, we address the fundamental question: Is there
an underlying “code” in lncRNA and mRNA promoter and en-
hancer sequences that accounts for their established differences
in tissue specificity and abundance? To address this, weused amas-
sively parallel reporter assay (MPRA)—in which thousands of reg-
ulatory sequences of interest are assayed in a single experiment
(Melnikov et al. 2012; Patwardhan et al. 2012)—to dissect core pro-
moter sequence properties at high resolution and across multiple
cell types. MPRAs have previously uncovered important character-
istics of promoters and enhancers (Nguyen et al. 2016; Arnold et al.
2017), but to date a systematic analysis of whether intrinsic fea-
tures of DNA sequence are responsible for differential activity at
lncRNA promoters, protein-coding gene promoters, and enhanc-
ers has not been performed.
Results
Divergent lncRNA core promoters are strong and ubiquitously
expressed
We first defined five biotypes: (1) eRNAs (RNAs emerging from bi-
directionally transcribed enhancers that do not overlap protein-
coding genes); (2) intergenic lncRNAs (lincRNAs); (3) divergent
lncRNAs (lncRNAs that share promoters with either a protein-
coding gene or another lncRNA in the antisense direction); (4)
mRNAs; and (5) divergent mRNAs (mRNAs that share promoters
with either another protein-coding gene or a lncRNA in the anti-
sense direction) (Fig. 1A;Methods). Note that here the term “diver-
gent” refers to the presence of a stable annotated transcript in the
antisense direction, not the potential bidirectionality of the pro-
moter itself. Because the TSSs of lncRNAs can be more poorly an-
notated than the TSSs of mRNAs, which could bias results when
comparing them (Lagarde et al. 2017), we carefully selected a set
of high-confidence TSSs defined by The FANTOM5 Consortium
across all biotypes. Specifically, we used the stringent set of en-
hancer TSSs (for eRNAs) and promoter TSSs (for the remaining bio-
types) defined as “robust” in the FANTOM5 project (Andersson
et al. 2014; The FANTOM Consortium and the RIKEN PMI and
CLST [DGT] 2014). For the promoter TSSs, we only considered
TSSs that were within 50 bp of an annotated gene start site
(Methods). In total, our genome-wide set of core promoter regions
included 29,807 eRNAs, 4280 lincRNAs, 1713 divergent lncRNAs,
14,332 mRNAs, and 4235 divergent mRNAs. Analysis of cap anal-
ysis of gene expression followed by sequencing (CAGE-seq) data
across 550 tissues and cell types (973 samples) for each TSS
confirmed that mRNAs were more highly expressed and less tissue
specific than lncRNAs and eRNAs (Supplemental Fig. S1). Addi-
tionally, for both lncRNAs and mRNAs, divergent transcripts
were more highly expressed and less tissue specific than their non-
divergent counterparts (Supplemental Fig. S1; Supplemental
Methods, Genome-wide Analysis section).
To experimentally test the previously mentioned computa-
tional predictions and dissect the contribution of DNA sequence
to the observed expression and tissue-specificity patterns, we de-
signed an MPRA in which we could assess the activity of 2078
unique TSSs encompassing all five biotypes (564 eRNAs, 525
lincRNAs, 353 divergent lncRNAs, 599 mRNAs, and 137 divergent
mRNAs) expressed across three diverse human cell lines: K562
(chronic myelogenous leukemia), HepG2 (liver carcinoma), and
HeLa (cervical adenocarcinoma) (Fig. 1A,B; Supplemental Table
S1; Methods). Since most TF motifs and ChIP-seq peaks were en-
riched near the TSS (Supplemental Fig. S2), we designed oligonu-
cleotides that spanned the core promoter (from 80 bp upstream
to 34 bp downstream from the TSS) (Methods). We linked each
core promoter to a minimum of 15 unique 11-nt barcodes to en-
sure redundancy across sequencing measurements (Supplemental
Table S2). We performed a minimum of four replicates and a max-
imum of 12 replicates per condition. We measured a sequence’s
ability to drive transcription—termed “MPRA activity”—by calcu-
lating the fold change between RNA barcode counts and input
DNA library barcode counts after normalizing for sequencing
depth (Methods). MPRA activity measurements across replicates
within a given condition were highly correlated (Supplemental
Fig. S3).
We first validated the MPRA by comparing core promoter ac-
tivitymeasurements tonegativecontrols; as expected, corepromot-
ers were significantly more active than random sequences in all
three cell types (Fig.1C; Supplemental Fig. S4). Ingeneral,MPRAac-
tivities correlated well with endogenous CAGE-seq expression
(Supplemental Fig. S5). eRNAs had the lowest activity, followed
by lincRNAs, which is consistent with the CAGE-seq results and
indicates that lincRNA core promoters are stronger than eRNA
core promoters (Fig. 1C; Supplemental Fig. S4). As we saw using
CAGE-seq expression, we found that divergent mRNAs were more
active than nondivergent mRNAs, and that divergent lncRNAs
were more active than intergenic lncRNAs (Fig. 1C; Supplemental
Fig. S4). This implies that, on average, an individual divergent pro-
moter is stronger than an individual nondivergent promoter.
Therefore, thehigherCAGE-seqexpression levelsobserved indiver-
gent lncRNAs compared to lincRNAs cannot solely be explained
by having two promoters in close proximity. When looking at ex-
pression-matched core promoters only, these results were substan-
tially weakened (Supplemental Fig. S6), indicating that we are
capturing innate expression differences between biotypes.
We further tested whether our MPRA could recapitulate en-
dogenous cell-type–specificity patterns. Briefly, we recalculated tis-
sue-specificity values using K562, HepG2, and HeLa CAGE-seq
expression data only (termed “cell-type specificity”) and found
that 67% of sequences agreed in CAGE-seq and MPRA cell-type–
specificity designations (i.e., were classified as either specific in
both or nonspecific in both) (Fig. 1D). Consistently, eRNAs and
lincRNAs were more tissue specific than mRNAs and divergent
transcripts (Fig. 1E). Thus, the DNA sequences of core promoter re-
gions alone drive part of the tissue-specificity pattern that is pre-
sent endogenously.
We next sought to determine whether differences in expres-
sion patterns between biotypes are associated with known core
promoter elements. Core promoters are often classified into two
types: ubiquitously expressed promoters (associated with CpG is-
lands and a depletion of TATA box motifs) and tissue-specific
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Figure 1. Core promoter sequences of different TSS classes vary in strength and cell-type specificity. (A) Overview of TSS classification based on element
class (lncRNA, mRNA, or eRNA) and presence or absence of a divergent stable transcript arising from the same promoter region on the antisense strand.
(B) Schematic of MPRA experimental design. (Min. prom.) Minimal promoter. (C) Comparison of MPRA activities (fold change between normalized RNA
barcodes and input DNA barcodes) of the reference sequences of each TSS class to negative control sequences in K562 cells. Only TSSs thatmeet the quality
criteria of three or more barcodes represented each with five or more DNA and RNA counts are plotted and n values are shown. P-values listed are from a
two-sided Wilcoxon test. (D) Correlation between CAGE cell-type specificity calculated across HeLa, HepG2, and K562 (x-axis) and MPRA cell-type specif-
icity across the same three cell lines (y-axis). The upper right and lower left quadrants correspond to sequences that agreewith CAGE andMPRA andmake up
67% of sequences. Dashed horizontal and vertical line thresholds for specificity were determined from the distribution of specificity values, shown as density
plots on the top and to the right of the main plot. Spearman’s ρ and P-value are shown. (E) Percent of sequences that are active in only one cell type (solid
bars) or all three cell types (K562, HepG2, and HeLa; hatched bars) within each biotype.
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promoters (enriched for TATA box and Initiator [Inr] motifs)
(Medina-Rivera et al. 2018). As expected, we found thatmore ubiq-
uitously expressed biotypes had higher CpG content (Supplemen-
tal Fig. S7A). All biotypes had similar numbers of sequences
containing Inrmotifs (Supplemental Fig. S7B). Very few sequences
(∼3%) had canonical TATA box motifs, which are traditionally as-
sociated with tissue-specific expression. Although eRNAs and
lincRNAshadmore TATAboxes thandivergent lncRNAs and diver-
gent mRNAs, mRNAs had a relatively high number of TATA boxes
and equally high numbers of both TATA boxes and Inr motifs to-
gether (Supplemental Fig. S7C,D). Thus, it would appear that tissue
specificity cannot be explained by core promoter elements alone,
because mRNAs, which are more ubiquitously expressed than
eRNAs and lincRNAs, are enriched for more canonical tissue-spe-
cific core promoter elements such as the TATA box.
Fewer overlapping TF motifs in lincRNAs and enhancers
contribute to their lower expression levels and higher cell-type
specificity
Our earlier results showed that MPRA can partially recapitulate
endogenous patterns of gene expression, including abundance—
for which MPRA activity is a proxy—and cell-type specificity.
Therefore, we aimed to further understand what sequence features
could be contributing to the lower abundance and higher tissue
specificity of eRNA and lincRNA core promoters. To that end, we
focused on two main features: TF motif architecture within a
core promoter sequence and the cell-type specificity of the TFs
themselves that are present within a core promoter sequence. To
determine core promoter TF motif architecture, we first mapped
motifs (corresponding to 519 TFs) within our core promoter se-
quences using FIMO (Grant et al. 2011). Since the presence of a
computationally predicted motif does not always indicate physio-
logical binding of the TF (Wasserman and Sandelin 2004), we then
intersected these mappedmotifs with ChIP-seq peaks correspond-
ing to 771 TFs (218 of which we had motifs for) (Mei et al. 2017)
and considered only the motifs that overlap a corresponding
ChIP-seq peak (Methods). We divided TF motif architecture into
two components: (1) the number of independent motif binding
sites in linear sequence space; and (2) the number of overlapping
motifs, which should be proportional to the number of different
TFs that can bind to a specific sequence pattern. As a proxy for
the number of independent motif binding sites, we used the num-
ber of base pairs covered by at least one motif in a given sequence.
As a proxy for the number of overlapping motifs, we used the
maximum coverage of motifs per sequence. As a proxy for the
cell-type specificity of the TFs themselves, we calculated the
mean cell-type specificity (across HepG2, HeLa, and K562) of all
TF motifs within a given promoter (Fig. 2A).
To test the relative importance of these three components
(number of base pairs covered by a motif, maximum coverage of
motifs, and average TF cell-type specificity), we calculated the pro-
portion of the variation in bothMPRA activity andMPRA cell-type
specificity that can be explained by each measurement using a ge-
neral linear model (Methods). The number of overlapping motifs
explains a slightly higher proportion of the variation than the
number of base pairs covered by a motif when predicting either
mean MPRA activity or MPRA cell-type specificity (Fig. 2B,C).
Conversely, the cell-type specificities of the TFs themselves
explain relatively little of the variation in MPRA activity and cell-
type specificity (Fig. 2B,C). We also evaluated how much individ-
ual TF motifs contribute to sequence activity (Methods). No single
TFmotif was able to explain >1.5% of the variation (Supplemental
Fig. S8B). Overall, our model suggests that having highly overlap-
ping motifs is substantially predictive of higher transcriptional ac-
tivity and decreased cell-type specificity.
Next, we looked at the motif architecture in biotypes that
are known to be tissue specific (such as eRNAs and lincRNAs) com-
pared to biotypes that are known to be ubiquitous (such asmRNAs
and divergent genes). We observed that tissue-specific biotypes
had both fewer base pairs covered by amotif and fewer overlapping
motifs than ubiquitously expressed biotypes (Fig. 2D). We then
classified individual lincRNA andmRNATSSs as being either ubiq-
uitously expressed (>0 CAGE tpm in >90% of samples), tissue
specifically expressed (>0 CAGE tpm in <10% of samples), or
dynamically expressed (a subset of tissue-specific genes, where in
at least one sample the TSS is expressed at >50 CAGE tpm).
Ubiquitously expressed TSSs within each biotype had both more
base pairs covered by amotif andmore overlappingmotifs than tis-
sue-specific and dynamic TSSs (Fig. 2E).
Some TF motifs are highly similar to each other, creating po-
tential redundancies in motif databases (Mathelier et al. 2014).
To control for this, we used two independent methods to cluster
similar motifs. First, we performed unbiased clustering of the 519
motifs using MoSBAT (Lambert et al. 2016), resulting in 223 motif
clusters (Supplemental Fig. S9A). Second, we used a list of 108 non-
redundant 8-mer motifs generated using protein binding microar-
rays across 671 TFs (Mariani et al. 2017). We then recalculated the
precedingmetrics (number of base pairs covered by amotif and the
maximum motif coverage) after removing each set of redundant
motifs.We found that for bothmetrics, ubiquitouslyexpressedbio-
types had higher maximum coverage values than tissue-specific
biotypes (Supplemental Figs. S9B,C, S10, S11). Moreover, DNA re-
gions that harbor many overlapping TF motifs are more conserved
than those harboring only one TF motif (Fig. 2F) and more DNase
accessible across tissues (Supplemental Fig. S12). Thus, using com-
putationallymapped TFmotifs, endogenous TF binding events via
ChIP-seq, and unique TF clusters, we observe that high and ubiqui-
tous expression is correlated with many overlapping motifs.
Targeted deletions refine functional TF motifs in lncRNA
promoters
Our results suggest that overlapping TF motifs that can be bound
bymany different TFs—potentially in different contexts—are asso-
ciated with increased expression and decreased tissue specificity.
We thus hypothesized that disruption of highly overlapping mo-
tifs should have larger effect sizes than disruption of more specific
motifs. To test this, we performed a second MPRA across the core
promoters of 21 disease-associated lncRNAs, five nearby mRNAs,
and five nearby eRNAs (Supplemental Table S3) and tested the ef-
fect of single-nucleotide deletions across each core promoter in
HepG2 and K562 cells (Fig. 3A; Supplemental Table S4). To ensure
that we covered all motifs surrounding the TSS, we included two
tiles for each TSS (from 183 bp upstream to 69 bp upstream and
89 bp upstream to 25 bp downstream from the TSS). Thus, this
strategy allows us to assess the contribution of each individual nu-
cleotide to core promoter activity independently in a single exper-
iment (Patwardhan et al. 2009).
First, we confirmed that test core promoter sequences had sig-
nificantly more activity than negative control sequences in both
cell types (Supplemental Fig. S13). Next, we calculated the “effect
size” of each deletion as a fold change in MPRA activity relative to
the full reference sequence. In order to determine how deletion
Mattioli et al.
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Figure 2. Coverage of TFs within a binding site explains expression levels and cell-type–specificity variability. (A) Schematic of the three metrics used to
model the capacity to drive transcription and cell-type specificity in theMPRA. For eachmetric, only TFmotifs that have been validated by ChIP (i.e., overlap
a ChIP peak for the cognate TF) are considered. (B) Fraction of variance explained by each of the three metrics for either meanMPRA activity (top) or MPRA
cell-type specificity (bottom). (C ) Correlation between the three metrics (x-axis) and either the mean MPRA activity (top) or MPRA cell-type specificity (bot-
tom) across HeLa, HepG2, and K562. Spearman’s ρ is shown. (D) Cumulative density plot of the number of base pairs covered by a motif across all biotypes
(top) and themaximummotif coverage across all biotypes (bottom). (E) Cumulative density plot for number of base pairs covered (top) andmaximummotif
coverage (bottom) either within lincRNAs (left) or within mRNAs (right), looking only at TSSs that are defined as tissue-specific (tissue-sp.), ubiquitous, or
dynamically expressed (see text). (F) Metaplot of the average phyloP 46-way placental mammal conservation score centered on motif regions, broken up
by how many individual TF motifs map to the region. In all plots, only sequences with at least one validated motif were considered.
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effect sizes correlate with TFmotif profiles, we calculated the num-
ber of computationally mapped motifs that are lost (or gained) in
each deletion sequence relative to the full reference sequence (Fig.
3B). Individual nucleotides that overlap a predicted motif are im-
portant in maintaining transcription, as deletion of each nucleo-
tide independently shows a strong loss of activity (Fig. 3B, gray
shaded area). Additionally, we also saw deletions with gain-of-
function effects, for example, deleting a single nucleotide in the
lncRNA HOTAIR core promoter is predicted to create 20 new TF
motifs and causes a strong increase in activity (Fig. 3B, red shaded
area). These observations extended to the remaining core promot-
ers: Deletion effect sizes were generally correlatedwith the number
of motifs computationally predicted to be affected by each dele-
tion (Fig. 3C; Supplemental Fig. S14A).
Moreover, single-nucleotide deletions can be used to better
identify functional DNA regulatory motifs than computational
motif mapping, because the strategy directly tests whether specific
nucleotides are required for transcription in a particular cellular
context (Supplemental Fig. S14B). We therefore took advantage
of the fact that functional DNA regulatory regions appear as
“peaks” in the deletion effect size map and intersected these peaks
with computationally mapped motifs (Fig. 3A). Of all of the com-
putationally mapped motifs in these sequences, 41% and 49%
were found to be functional in the tested cell line, i.e., overlapped
deletion peak regions, in HepG2 and K562, respectively. For exam-
ple, the lncRNA DLEU1, which is frequently lost in lymphocytic
leukemia (Liu et al. 1997), contains eight predicted TF motifs,
but only onemotif (NRF1) significantly overlapped the peak found
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Figure 3. Targeted deletions refine TFmotifs within lncRNA promoters. (A) Schematic of the single-nucleotide deletionMPRA design (left) and the output
interpretation (right). (B) MPRA deletion profile for the lncRNA HOTAIR promoter (top), the positions of computationally mapped motifs in the reference
sequence (middle), and the number of motifs predicted to be gained or lost due to the single-nucleotide deletions (bottom). Shaded areas represent the
strongest gain (red) or loss (gray) of activity. (C) Correlation between the number of motifs predicted to be disrupted (x-axis) and the effect size of deletions
(y-axis) for all significant deletions in HepG2. (D, top) MPRA deletion profile for the lncRNA DLEU1 promoter. Shaded area is a called peak. (Bottom) DLEU1
sequence (plotted with letter heights proportional to loss of activity in theMPRA) and computationally mappedmotifs (gray boxes). The sequence logo for
NRF1 is shown. (∗) TFAP2A, TFAP2B, and TFAP2C all map to the noted gray box. (E) Heatmap showing all computationally mapped motifs that overlap
deletion peaks in HepG2.
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via single-nucleotide deletions (Fig. 3D). Therefore, we hypothe-
size that NRF1, which has a known role in the immune system
(Suliman et al. 2010), is the primary and direct regulator of
DLEU1. Consistent with this, NRF1 also has a corresponding
ChIP peak in the DLEU1 promoter. In total, we were able to deter-
mine a wide range of functional TF motifs in 15 lncRNAs, three
eRNAs, and three mRNAs (Fig. 3E; Supplemental Fig. S15). These
results show the utility of MPRA in combination with single-
nucleotide deletions to refine functional TFs.
Finally, we reexamined the idea that sequences that can be
bound bymany TFs are more broadly expressed. Indeed, we found
that sequences that were active in both cell types had more of our
detected functional TF motifs than sequences that were active in
only one of the tested cell types (P=0.061, one-sided Wilcoxon
test) (Supplemental Fig. S16). This again suggests that the more
TFs a sequence can bind, the broader its expression pattern.
More than 20% of genetic variants within core promoters have
regulatory effects
We extended our single-nucleotide MPRA studies to examine how
human variation affects promoter activity in contrast to engi-
neered deletions. Briefly, we used MPRA to identify regulatory
SNPs that could affect a sequence’s ability to drive transcription
in our set of 21 disease-associated lncRNA core promoters. The ef-
fect sizes of the tested SNPs were highly correlated with the dele-
tion effect sizes (Supplemental Fig. S17A). More importantly,
significant SNPs tended to occur in peaks corresponding to TFmo-
tifs (Supplemental Fig. S17B). In fact, 78% and 90%of significantly
regulatory SNPs that decrease expression overlapped deletion-
predicted TF peaks in HepG2 and K562, respectively, compared
to only 9% and 5% of nonregulatory SNPs. The tumor suppressor
lncRNAMEG3, for example, harbors one regulatory SNP shown to
bemutated in breast cancer tumors by two separate studies (Forbes
et al. 2017). This SNP lies in a functional TF peak predicted to har-
bor binding sites for the CREB family of TFs (Supplemental Fig.
S17B). Together, these results show that our MPRA strategy can
identify regulatory SNPs that disrupt functional TF motifs.
To gain awiderunderstandingofhowgenetic variation affects
DNA regulatory elements, we next used MPRA to test all common
SNPs annotated in our set of approximately 2000 core promoters
in HepG2 and K562 (Fig. 4A). We correctly identified 100% and
71% of positive control variants as significantly regulatory in
HepG2 and K562, respectively (Supplemental Fig. S18). As with
the deletion effect sizes, SNP effect sizes also correlated with the
number of predicted TF motifs disrupted by the SNP (Fig. 4B;
Supplemental Fig. S19), again suggesting that disruption of multi-
ple overlappingmotifs is associatedwith larger expression changes.
Overall, we found that as many as 22% of SNPs in the tested
TSS regions have an effect on promoter strength (Supplemental
Table S5; Supplemental Fig. S20). We predict that this proportion
would increase with a higher number of barcodes (Supplemental
Fig. S21A) and replicates (Supplemental Fig. S21B). When we
looked within each biotype, we found no differences in the num-
ber of regulatory SNPs or in the SNP effect sizes (Supplemental Fig.
S22). We found that 55% of regulatory SNPs have an effect in only
one of the two cell types (Fig. 4C).
Due to linkage disequilibrium (LD) in the human genome,
multiple individual SNPs tend to be inherited together in haplo-
types. However, how individual SNPs interact within a haplotype
remains unclear. We therefore sought to determine whether indi-
vidual SNPs in TSSs tend to interact additively (i.e., the effect of all
SNPs together is equal to the sum of their individual effects) or
epistatically (i.e., the effect of one SNPmasks the effects of the oth-
er SNPs). We found that a minority of SNPs acted epistatically
because only 16% and 22% of SNPs had a nonadditive effect in
HepG2 and K562, respectively (Fig. 4D).
Finally, we sought to identify regulatory SNPs that are in LD
with GWAS hits. We identified 96 and 36 such SNPs in HepG2
andK562, respectively (Supplemental Table S6). To analyze the pu-
tative relationship between the regulatory potential of an MPRA-
tested SNP and the GWAS-associated phenotype, we selected
SNPs that (1) are regulatory SNPs in both HepG2 and K562 cells
(32 total); (2) disrupt knownTFmotifs; and (3) have nearby coding
genes thatareassociatedwith theGWAS-associatedphenotype.We
identified three SNPs with significant regulatory effects in both
HepG2andK562 cells that are associatedwith levels ofHDLcholes-
terol (rs3785098) (Willer et al. 2013), lungcancer (Wanget al. 2008)
or schizophrenia (rs3101018) (Goes et al. 2015), and inflammatory
bowel disease (IBD) (rs4456788) (Liu et al. 2015), respectively (Fig.
4E; Supplemental Fig. S23). For example, the IBD-associated SNP
rs4456788 disrupts six TF motifs and shows significantly lower
MPRA activity compared to the reference allele (Fig. 4E). As well
as being associated with IBD, this SNP is known to be an eQTL for
the protein-coding gene ICOSLG (The GTEx Consortium 2015);
thus, thisMPRAresult couldprovide an important clue—anda test-
able hypothesis—as to the biological pathway that is responsible
for this genetic association.
Discussion
Here, we have characterized the differences between lncRNA,
mRNA, and eRNA core promoter sequences by combining compu-
tational predictions and experimental testing using high-through-
put assays. Because many lncRNAs are thought to arise from
enhancers (Marques et al. 2013) or bidirectional transcription
stemming from protein-coding promoters (Sigova et al. 2013),
we sought to determinewhether lncRNApromoters are intrinsical-
ly different from enhancers and protein-coding promoters. Our
findings suggest that the regulation of divergent lncRNAs and
intergenic lncRNAs are quite different. Divergent lncRNAs have
more TF motifs and consequently have stronger promoters than
intergenic lncRNAs. Notably, higher expression levels of divergent
lncRNAs compared to lincRNAs cannot solely be explained by hav-
ing a nearby protein-coding promoter. Rather, we show that both
divergent lncRNA and mRNA core promoters are intrinsically
stronger than nondivergent lncRNA and mRNA promoters (Fig.
1C). Conversely, intergenic lncRNA TSSs are similar to enhancer
TSSs, both in terms of their TF motif architecture and expression
patterns, with both biotypes being highly tissue specific (Fig. 2D).
Our results suggest that core promoter sequences play impor-
tant roles in determining transcript tissue specificity, because our
MPRA results can partially recapitulate endogenous expression
patterns (Fig. 1D,E). Importantly, using MPRA allows us to thor-
oughly interrogate the regulatory potential of DNA sequence alone
while controlling for other factors such as chromatin differences
and effects of post-transcriptional regulation. However, we recog-
nize that this study has some limitations that are intrinsic to using
episomal plasmids inMPRA. These limitations are reflected within
our own data, in which sequence alone only accounts for ∼50% of
observed expression profiles when modeled. Nonetheless, our ap-
proach has characterized the baseline to which higher-order struc-
tural and epigenetic information can be added in order to gain a
more complete picture of transcriptional regulation.
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Our data are consistent with a model in which highly abun-
dant genes have complex TF bindingprofiles, with stretches of pro-
miscuousDNA that can be recognized bymany TFs (Fig. 5). Several
lines of evidence point toward overlapping binding sites playing a
role in determining abundance and tissue specificity. First, we see
that a model trained on MPRA data finds the number of overlap-
ping motifs to be highly predictive of abundance and anticorre-
lated to cell-type specificity (Fig. 2B,C). Second, we find that
tissue-specific biotypes have fewer overlappingmotifs thanubiqui-
tously expressed biotypes (Fig. 2D). We also find that within one
biotype, tissue-specific genes have fewer overlapping motifs than
ubiquitously expressed genes (Fig. 2E). Third, we show that se-
quences that are expressed in both HepG2 and K562 have more
functional motifs than sequences that are only expressed in one
cell type (Supplemental Fig. S16). Finally, we see that both single-
nucleotide deletions and SNPs that are predicted to disrupt more
motifs have higher effect sizes (Figs. 3B, 4B). For example, a sin-
gle-nucleotide deletion in the HOTAIR promoter generates 20
new TF motifs and subsequently increases promoter activity by
fourfold (Fig. 3B).
By definition, overlapping binding sites are at the same dis-
tance from the TSS; interestingly, where TFs bind in relation to
the TSS is important (Tabach et al. 2007). We speculate that this
system would allow genes to maintain high and ubiquitous ex-
pression levels across different tissues and conditions despite the
likely fluctuating expression levels of the TFs. Further, this redun-
dancy could explain why knockdown of certain TFs often does
not result in the misregulation of the expected target genes
(Cusanovich et al. 2014), as other TFs would be able to bind to
the same position. Thus, we propose that promoter specificity
may be a function of simplicity in motif usage. Further work re-
mains to be done to experimentally test the extent of the role
that these overlapping motif profiles play in regulating expression
and specificity.
E
BA C
D
Figure 4. Twenty-two percent of SNPs in promoter and enhancer TSSs have regulatory effects. (A) Schematic of SNP and haplotype testing in MPRA.
(B) Correlation between the number of TF motifs disrupted (x-axis) and the SNP effect size (y-axis) for all significant SNPs in HepG2. SNP effect size is
the mean log2 fold change in MPRA activity between the alternative and reference alleles. (C) Correlation between SNP effect sizes in HepG2 (x-axis)
and K562 (y-axis). (D) Examples of two haplotype effects, one additive (top) and one super additive (bottom). Dots represent barcode activity means across
replicates for reference tile (light gray), individual SNP tiles (dark gray), or haplotype tiles (red). Shaded red area in the haplotype column refers to the 90%
confidence interval surrounding the expectedmedian additive effect. (E) Example of a SNP near ICOSLG that disrupts six TFmotifs present on the reference
allele. The difference in MPRA activity between the reference and alternative alleles in HepG2 is shown. P-value listed is from a two-sided Wilcoxon test.
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Our findings also have evolutionary implications. Much at-
tention has been given to the fact that enhancers and lincRNAs
have rapid sequence turnover (Hon et al. 2017). Our findings are
consistent with this notion. We find that tissue-specific TSSs,
such as those of lincRNAs and eRNAs, have less complexmotif pro-
files. Thus, they may be more likely to appear and disappear
throughout evolutionary time. In fact, DNA regions with few over-
lapping motifs are more poorly conserved than DNA regions with
many overlapping motifs (Fig. 2F). Conversely, highly transcribed
genes have developed more complex TF binding patterns, which
may have evolved to produce stable antisense transcripts because
they provide a fitness advantage. Indeed, if we compare human
and mouse orthologous genes that have gained a stable antisense
transcript in either one of the lineages, they show an overall in-
crease in expression (Supplemental Fig. S24). Thus, bidirectional
transcription may not only allow for de novo gene origination
but could also be an evolutionary mechanism to increase expres-
sion of the gene in the sense direction. This may also help explain
why divergent mRNA–lncRNA pairs occur so frequently in the hu-
man genome (Sigova et al. 2013). Overall, this study sheds light on
the important roles that core promoters play in complicated as-
pects of gene regulation, including divergent transcription and tis-
sue specificity, across both coding and noncoding genes.
Methods
TSS biotype classification
mRNA and lncRNA TSSs were classified based on GENCODE
v19 (Harrow et al. 2012) gene annotations. All TSSs from genes
annotated as lncRNAs were classified as intergenic lncRNA
(lincRNA) TSSs if they did not overlap any annotated protein-
coding genes or as divergent lncRNA
TSSs if the annotated TSS had an anti-
sense FANTOM5 TSS within 1000 bp.
Similarly, mRNA TSSs were classified as
divergent mRNA TSSs if the annotated
TSS had an antisense FANTOM5 TSS
within 1000 bp. eRNA TSSs were also de-
fined by FANTOM5 (Andersson et al.
2014) and had two TSSs each—a sense
TSS and an antisense TSS—due to their
inherent definition of being bidirection-
ally transcribed.
MPRA TSS selection
To select promoters to include in the
MPRA, we used the FANTOM5 robust
TSS set (The FANTOM Consortium and
the RIKEN PMI and CLST [DGT] 2014).
These TSSs are expressed robustly in
CAGE-seq data (more than 10 CAGE
reads in one sample and >10 tpm CAGE
expression in at least one sample). Addi-
tionally, we only considered FANTOM5
TSSs that were within 50 bp of their cog-
nate annotated GENCODE v19 tran-
script TSSs. eRNA TSSs were selected
from the enhancer TSS set defined in
the same FANTOM5 release (Andersson
et al. 2014). Next, we selected TSSs based
on their CAGE expression profiles. Spe-
cifically, we required the TSSs to either
(1) be expressed >0.5 tpm across all replicates of at least one of
the tested cell lines (HeLa, HepG2, or K562); or (2) have an average
expression >0.5 tpm across all FANTOM5 samples (suggesting they
had high baseline expression). Finally, we excluded any lncRNA
TSSs arising from transcripts with high coding potential (phy-
loCSF >0) (Lin et al. 2011) or that overlapped a protein-coding
gene in the sense direction.
Because the MPRA was lncRNA-focused, all lncRNA TSSs
(lincRNAs and divergent lncRNA TSS) that filled the aforemen-
tioned criteria were included for testing in the MPRA. To control
for the fact that there were more mRNA and eRNA TSSs than
lncRNAs, we selected both expression-matched mRNA and eRNA
TSSs (average expression across all FANTOM5 samples matching
that of lncRNA TSSs) as well as randomly selected mRNA and
eRNATSSs for further analysis.We also included all protein-coding
TSSs that were in close proximity to the selected lncRNA TSSs
(<160 bp) in antisense and some of the most highly expressed
eRNAs. Additional TSSs were included if they contained at least
one SNP in LD with a GWAS hit in their core promoters (for addi-
tional details, see Supplemental Table S6). Overall, we ended up
with 2078 TSSs for testing in MPRA (Fig. 1A; Supplemental Table
S1). More details are available in Supplemental Methods (MPRA
TSS Selection section).
MPRA pool design
Two 120,000 oligonucleotide (oligo) pools of 170 bp with 11-bp
barcodes were designed. The first pool included core promoter se-
quences across biotypes and common SNPs falling in these regions
(Supplemental Methods; Supplemental Tables S1, S2). The second
pool included single-nucleotide deletions across the core pro-
moters of 21 lncRNAs, five enhancers, and five mRNAs with
two consecutive reference tiles each (Supplemental Methods;
Figure 5. In this model, overlapping TF motifs are associated with high expression and low specificity.
Schematic showing biotypes that are highly and ubiquitously expressed (left; thick arrow) have more
overlapping TF binding sites (gray shaded boxes) and thus more TFs can bind both within a specific
cell type or across cell types. Biotypes that are lowly and specifically expressed (right; thin arrowor crossed
arrow) have fewer overlapping motifs and thus only a few TFs (one in the example) can bind. TFA is pre-
sent in cell types 1 and 2, whereas TFB and TFC are only present in cell type 1 and cell type 2, respectively.
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Supplemental Tables S3, S4). Random and scrambled sequences
were included in both pools as negative controls. More details
are available in Supplemental Methods (MPRA Oligo Pool Design
section).
MPRA cloning and transfection
Oligo poolswere synthesized by Twist Biosciences and then cloned
into plasmids to generate a library of constructs in which the
regulatory sequence is upstream of a reporter gene (here, GFP)
that is upstream of a unique barcode (Supplemental Methods).
Constructs were transfected into live cells, and barcode expression
was assayed by high-throughput RNA sequencing. A minimum of
four and a maximum of 12 replicates were performed per condi-
tion (cell type and presence/absence of a minimal promoter) add-
ing up to 32 total experiments (Supplemental Fig. S3). Results are
based on theminimal promoter setup given the high similarity be-
tween replicates with and without the minimal promoter and the
fact that more replicates were performed for this setup. More de-
tails are available in Supplemental Methods (MPRA Cloning,
Transfection, and Sequencing section).
MPRA data analysis
All Python scripts and notebooks used to perform the MPRA
analyses are available at https://github.com/kmattioli/2018__
lncRNA_promoter_MPRA and provided as Supplemental Code.
Exact matches to known barcodes and six upstream constant
nucleotides were mapped after quality-filtering the sequencing
reads. Barcodes were filtered to those with five or more counts
(in both DNA and RNA). Barcode activities were calculated as the
log-transformed proportion of RNA barcodes to the proportion
of DNA barcodes (after normalizing for sequencing depth) and
were quantile-normalized across replicates. Element activities
were calculated as the median activity value across all cognate
barcodes, requiring three or more barcodes. Significantly active
tiles were defined as those with barcode activities that were signifi-
cantly higher than random negative control sequences according
to a two-sided Wilcoxon test in ≥75% of replicates (Supplemental
Methods). Becausewe hadmanymore replicates in HepG2 than in
other cell types and to ensure we had similar power when compar-
ing across cell types (i.e., Fig. 1F), HepG2 replicates were down-
sampled 100 times and sequences were considered significant if
they were significant by the rules above in ≥75% of samples.
More details are available in Supplemental Methods (MPRA Anal-
ysis section).
Core promoter element analysis
The core promoter was defined as 80 bp upstream to 34 bp down-
stream from the TSS. CpG content was calculated by counting the
number of “CG” dinucleotides in this region. Inr motifs were de-
fined to be matches to the motif BBCABW (B=C/G/T, W=A/T)
(Kugel and Goodrich 2017) within 5 bp of the TSS. TATA motifs
were defined to bematches to themotifs TATAAA or TATATAwith-
in 55–15 bp upstream of the TSS. Position weight matrices for TF
bindingmotifs were obtained from the JASPAR database (core, ver-
tebrates, 2016 release) (Mathelier et al. 2014).
MPRA activity and tissue-specificity predictions
An ANOVA analysis was used to evaluate what properties contrib-
ute to MPRA activity and specificity. Specificity across the MPRA
activity values for HepG2, K562, and HeLa was calculated using
the τ metric as follows (Kryuchkova-Mostacci and Robinson-
Rechavi 2017):
t =
∑n
i=1 (1− x̂i )
n− 1 ; x̂i =
xi
max
1≤i≤n
(xi)
,
where xi is the median activity of a TSS in cell type i; and n is the
number of cell types. Briefly, τ calculates the average difference be-
tween the activity of a TSS in a given cell type and the TSS’maxi-
mal expression across all cell types. Thus, “ubiquitous” TSSs will
have τ values close to zero while “tissue-specific” TSSs will have
τ values close to one.
To perform the ANOVA analysis, the variance in activity/spe-
cificity that is explained by the general sequence features (listed in
Supplemental Fig. S6A) was calculated. The variance explained by
each parameter was calculated on its own and the optimal subset
of parameters was computed. Because the parameters were highly
correlated, the optimal subset consisted of only seven of 14 param-
eters yet explained 41% of the total variance (Supplemental Fig.
S6A).
MPRA activity  CpG content+max(coverage)+ # bp covered
+CG content+CG content2 + total # motifs
+ total # motifs2
Motifs were then added into the model one by one.
MPRA activity  CpG content+max(coverage)+ # bp covered
+CG content+CG content2 + total # motifs
+ total # motifs2 +motif is present
Of the 382 motifs tested, 17 were found to explain a signifi-
cant fraction of the variance (listed in Supplemental Fig. S6B).
Combining the seven sequence features and the significant motifs
in a model explained a total of 49% of the variance in MPRA
activity.
This analysis was performed in R (version 3) using the leaps
and tidyverse packages (R Core Team 2018).
ChIP-seq analysis and TF motif mapping
ChIP-seq files were downloaded from the Cistrome Data Browser
(www.cistrome.org) (Mei et al. 2017) for 771 human TFs
(Supplemental Table S7)—218 of which overlapped with the set
of 519 JASPAR motifs. BEDTools (Quinlan and Hall 2010) was
used to merge peaks for a given TF and then intersect the merged
ChIP peaks with our set of promoters. Since Cistrome peaks were
in hg38 and our promoters were in hg19, we first used liftOver
(Hinrichs et al. 2006) to convert our promoters to hg38 coordi-
nates. Motifs were mapped in sequences using FIMO (version
4.11.2) (Grant et al. 2011) with a P-value threshold of 1 ×10−5.
Motifs were assigned to ChIP-seq peaks if there was a FIMO motif
mapped within 250 bp of the ChIP-seq peak.
Ubiquitous and tissue-specific TSS categorization
In order to categorize TSSs based on their expression profiles, we
used the FANTOM5 CAGE-seq expression data for both TSSs and
enhancers. We removed any FANTOM5 samples corresponding
to experimental time courses or fractionated cells and then
grouped the remaining samples by tissue or cell type (Supplemen-
tal Table S8). We then defined the following expression profiles:
ubiquitously expressed (>0 CAGE tpm in >90% of these grouped
samples), tissue specifically expressed (>0 CAGE tpm in <10% of
these grouped samples), or dynamically expressed (a subset of
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tissue-specific genes, where in at least one of the grouped samples
the TSS is expressed at >50 CAGE tpm).
MPRA deletion analysis and functional TF motif mapping
Deletion effect sizes were defined as the log2 fold change between
the mean activity of the deletion sequence across replicates and
the mean activity of the reference sequence across replicates, re-
sulting in a value per nucleotide. Peaks were defined as any stretch
of≥5 ntwith effect sizes of≥−1.5 × the average standard deviation
of the deletion effect sizes in that tile. Mapped motifs were said to
be “functional” if ≥1 nt in the motif intersected a peak.
SNP and haplotype analysis
Regulatory SNPs were defined as those whose barcode activities
were significantly different and consistent in direction between
reference and alternative tiles using a two-sided Wilcoxon test in
≥75%of replicates (SupplementalMethods). Again,when compar-
ing among cell types (i.e., Fig. 4C), HepG2 replicates were down-
sampled 100 times as previously mentioned in the “MPRA data
analysis” section.
To determine additive haplotypes, first the expected additive
haplotype effect size was found by summing the median log2 fold
changes (alternative/reference activities) for each individual SNP
in a haplotype. This effect was bootstrapped (n=1000) to deter-
mine a 90% confidence interval, and a haplotype was considered
additive if the actual median log2 fold change of the haplotype
fell within this 90% confidence interval.
The GWAS catalog was downloaded from https://www.ebi.ac
.uk/gwas/downloads. Raggr was used to calculate whether any of
the MPRA-tested SNPs were in linkage disequilibrium (r2 < 0.6)
with any of the GWAS tag SNPs at http://raggr.usc.edu/.
Data access
The MPRA sequencing data from this study have been submitted
to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi
.nlm.nih.gov/geo/) under accession number GSE117594. All
scripts required to reproduce this work are available as Supplemen-
tal Code as well as on GitHub at https://github.com/kmattioli/
2018__lncRNA_promoter_MPRA.
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